Featured Post from University of Delaware

Armed with a new NIH grant, UD's Day Lab targets difficult-to-treat diseases with breakthrough therapies

Oct 31, 2023

2 min


The University of Delaware's Day Lab, led by associate professor Emily Day, is conducting innovative research on high-precision therapies using unique nanoparticles. With a recent R35 grant from the National Institutes of Health (NIH), the lab aims to advance the design and use of nanoparticles for managing various diseases, including cancers, blood disorders, and reproductive health conditions. The lab specializes in developing nanomaterials with properties that allow them to target specific cells, evade immune detection and deliver therapeutic cargo effectively. The focus is on understanding the interaction of these nanoparticles with cells and tissues to improve the study, diagnosis, and treatment of diseases.


What sets Day's group apart is its ability to bridge the gap between fundamental research and practical applications in nanomedicine. The lab received an NIH Maximizing Investigators' Research Award (MIRA) to support their research for five years, providing stability and flexibility to pursue breakthroughs in overcoming biological barriers to nanoparticle delivery. Key research questions include understanding protein corona-mediated immune clearance and how nanoparticles cross blood vessel walls, addressing challenges in particle distribution and targeting. Overcoming these barriers could significantly enhance the clinical impact of nanomedicine and improve the treatment of various diseases.


While the lab's research is fundamental, its implications extend broadly across the field of nanomedicine. The discoveries made, particularly in membrane-wrapping research, may have applications in enhancing the effectiveness of treatments, such as mRNA COVID vaccines, by preventing clearance from the body.


Researchers are hopeful that their work will contribute to advancements in targeted therapies, making them more widely available for various diseases.


To arrange an interview with Day, visit her profile and click the "contact" button.

Powered by

You might also like...

Check out some other posts from University of Delaware

2 min

How AI can improve poor leadership writing and boost productivity

Poor written communication from leaders can create the kind of confusion it intended to avoid. University of Delaware career expert Jill Gugino Panté suggests using AI to sharpen emails, clarify expectations and reduce unnecessary calls. Getting through to employees with strong messaging can boost productivity by saving time and reducing unwanted meetings, she says. Panté, director of UD's Lerner Career Services Center, says that good leadership writing should be direct and outcome-driven, with no fluff, and offered the following advice for improvement. ✅ Don’t bury the lead. Start with what decision needs to be made, what action is required, and the deadline. If your writing doesn’t reduce ambiguity, it’s going to add to it. Vague communication can create interpretation gaps which, in turn, can create more meetings. When ownership isn’t defined, decisions aren’t documented, or outcomes aren’t clear, teams default to “Let’s hop on a call.” Meetings then become the fallback for unclear thinking. ✅ Generative AI can be a powerful clarity tool if it’s used intentionally. When used well, it can sharpen your ask and structure communication for action. The key is prompting it to refine your message, not just polish it. Leaders can use prompts like: • “Rewrite this message so the action, owner, deadline, and success metrics are explicitly stated" • “What assumptions or ambiguities exist in this message?” ✅ Good writing can replace unnecessary meetings. If communication is not direct, outcome-driven, and structured for action, it will cost you time somewhere else. Here are some practical actions that leaders can make in their writing: • Start with the Ask - Be explicit about what decision or action is needed. Don’t make people search for it. • Define Outcomes - Clarify deliverables, timelines, budgets and state what success looks like. • Clarify Ownership - Identify who is responsible for the request. • Document Decisions - Write down what has been decided and reiterate next steps, owners, and deadlines. To connect with Panté directly and arrange an interview, visit her profile and click on the "contact" button. Interested media can also send an email to MediaRelations@udel.edu.

1 min

Epidemiologist: Winter Olympics fortunate to dodge norovirus outbreak

Finland's Olympic women's hockey team overcame a norovirus scare last week, but they couldn't get past Team USA, who shut them out 5-0 Saturday in Milan. The University of Delaware's Jennifer Horney can discuss the difficult-to-contain virus, which also hit the Winter Games in 2018. - Horney, a professor of epidemiology at UD, said that the outbreak –  which forced Finland to cancel its first game after 13 players had either been infected or quarantined – is not surprising. Norovirus spreads rapidly in crowded environments through direct contact with surfaces or airborne droplets. - It is difficult to limit the spread of norovirus, as witnessed by the major outbreak that spread at the 2018 Winter Olympics in South Korea. - Consideration is often given for the potential of these types of outbreaks being intentional, which requires public health to work closely with law enforcement. To reach Horney directly and arrange an interview, visit her profile and click on the "contact" button. Interested journalists can also send an email to MediaRelations@udel.edu.

1 min

How ACL injury derailed Lindsey Vonn's heroic return to Olympic competition

An ACL rupture couldn't keep skiier Lindsey Vonn off the slopes to start this week's Olympics. But according to the University of Delaware's Dr. Karin Silbernagel, the injury likely contributed to her inability to land safely Sunday on the downhill course in Cortina d’Ampezzo, Italy. The crash ended her heroic return to competition Dr. Silbernagel, a professor of physical therapy, studies tendon injuries in the ankle and knee in elite athletes, especially Achilles ruptures and ankle function. She was quoted in an ESPN story about the rash of such injuries in the NBA and can specifically address the impact they could have on competition now and for the rest of an athlete's career. Her research shows that even after successful surgery, many athletes return to competition but not many among them return to peak explosiveness or durability. The impact a major injury would have on a fresh injury like Vonn's is obvious, she said. Dr. Silbernagel's research on ankle and knee injuries dates back to the early 2000s. She consults with professional sports teams relating to tendon injuries and is a consultant to the NFL's Musculoskeletal Committee. To connect directly with Dr. Silbernagel and arrange an interview, visit her profile and click the "contact" button. Interested members of the media can also send an email to MediaRelatons@udel.edu.

View all posts
Powered by